1. Home
  2. CACC vs RGEN Comparison

CACC vs RGEN Comparison

Compare CACC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CACC
  • RGEN
  • Stock Information
  • Founded
  • CACC 1972
  • RGEN 1981
  • Country
  • CACC United States
  • RGEN United States
  • Employees
  • CACC N/A
  • RGEN N/A
  • Industry
  • CACC Finance: Consumer Services
  • RGEN Medical/Dental Instruments
  • Sector
  • CACC Finance
  • RGEN Health Care
  • Exchange
  • CACC Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • CACC 6.3B
  • RGEN 6.6B
  • IPO Year
  • CACC 1992
  • RGEN N/A
  • Fundamental
  • Price
  • CACC $474.74
  • RGEN $124.35
  • Analyst Decision
  • CACC Sell
  • RGEN Buy
  • Analyst Count
  • CACC 2
  • RGEN 9
  • Target Price
  • CACC $475.00
  • RGEN $167.38
  • AVG Volume (30 Days)
  • CACC 106.2K
  • RGEN 1.0M
  • Earning Date
  • CACC 07-31-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • CACC N/A
  • RGEN N/A
  • EPS Growth
  • CACC 143.69
  • RGEN N/A
  • EPS
  • CACC 34.75
  • RGEN N/A
  • Revenue
  • CACC $1,173,200,000.00
  • RGEN $673,956,000.00
  • Revenue This Year
  • CACC $157.38
  • RGEN $14.14
  • Revenue Next Year
  • CACC $4.19
  • RGEN $14.32
  • P/E Ratio
  • CACC $13.66
  • RGEN N/A
  • Revenue Growth
  • CACC 43.92
  • RGEN 8.73
  • 52 Week Low
  • CACC $409.22
  • RGEN $102.97
  • 52 Week High
  • CACC $560.00
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • CACC 44.48
  • RGEN 54.96
  • Support Level
  • CACC $461.26
  • RGEN $111.15
  • Resistance Level
  • CACC $491.60
  • RGEN $127.57
  • Average True Range (ATR)
  • CACC 13.18
  • RGEN 4.80
  • MACD
  • CACC 0.61
  • RGEN 1.31
  • Stochastic Oscillator
  • CACC 47.43
  • RGEN 63.23

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: